STTK
Shattuck Labs, Inc.
$4.94
+18.18%
$378.8M
No data for this timeframe.
Vol
Market Cap$378.8M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (86%)
Inst. Holders35 funds
Inst. Value$96.0M
Inst. Activity9 buys / 2 sells
Insider Activity1B / 2S
Insider Net $$37.5K
SEC Reports12
Press Releases2
Recent Activity
Jun 11, 2026
SEC
Shattuck Labs closed a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $4.00/sh
8-K — Impact 6/10
Jun 11, 2026
SEC
This 13F institutional cluster for Shattuck Labs (STTK) reveals one mega-passive buyer (Bank of America doubling a tiny
INST-CLUSTER — Impact 4/10
Jun 11, 2026
SEC
Shattuck Labs is conducting a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $
424B5 — Impact 6/10
Jun 10, 2026
offering
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
<p>AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuc
Jun 9, 2026
Insider
SIEGALL CLAY B bought 62,500 shares
Director @ $4.00 ($250.0K)
Jun 8, 2026
Insider
Ashiya Mona acquired 15,366,490 shares
Director
Jun 8, 2026
Insider
Ashiya Mona disposed of 15,366,490 shares
Director
Inst.
ADAGE CAPITAL PARTNERS GP, — TRIM
4,644,957 shares ($29.9M)
Price Targets
$14.83
+200.3% upside
Strong Buy
Current $4.94
Low $10.00
Median $16.00
High $18.00
6 analysts
$10.00
$18.00
Analyst Ratings
3Strong Buy
9Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 9, 2026 | Citigroup | MAINTAIN | Buy → Buy |
| Jun 8, 2026 | Needham | MAINTAIN | Buy → Buy |
| Jun 8, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Jun 5, 2026 | Citigroup | UPGRADE | Neutral → Buy |
| May 8, 2026 | Wedbush | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.13 ▲ +3.9% | $-0.18 — $-0.09 | 45% YoY | 7 |
| Next Q | $-0.12 ▲ +4.3% | $-0.21 — $-0.08 | 12% YoY | 7 |
| Current FY | $-0.50 ▼ -8.2% | $-0.79 — $-0.38 | 28% YoY | 7 |
| Next FY | $-0.52 ▼ -0.8% | $-0.88 — $-0.34 | -3% YoY | 7 |
Latest Reports
BEARISH
8-K
6/10
Shattuck Labs closed a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $4.00/sh
Jun 11, 2026
BEARISH
INST-CLUSTER
4/10
This 13F institutional cluster for Shattuck Labs (STTK) reveals one mega-passive buyer (Bank of America doubling a tiny
Jun 11, 2026
BEARISH
Press
6/10
Shattuck Labs priced a public offering of 10,879,376 common shares at $4.00/share and pre-funded warrants for 7,870,624
Jun 10, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | TRIM |
| ADAGE CAPITAL PARTNERS GP, | $29.9M | TRIM |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.6M | — |
| Point72 Asset Management, L.P. | $6.6M | — |
| AMERIPRISE FINANCIAL INC | $5.8M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | SIEGALL CLAY | BUY | $250.0K |
| Jun 8, 2026 | Ashiya Mona | C | $0.00 |
| Jun 8, 2026 | Ashiya Mona | C | $0.00 |
| Jun 8, 2026 | ORBIMED ADVISORS | C | $0.00 |
| Jun 8, 2026 | ORBIMED ADVISORS | C | $0.00 |
35 institutional holders with $96.0M total value (16,800,484 shares) as of 2026-Q1. Top holders: ROYAL, ADAGE, VANGUARD. Net buying activity: 9 institutions added/increased vs 2 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 73 | $0.00 | 0.0% | TRIM -47.2% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,644,957 | $29.9M | 31.1% | TRIM -26.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2,277,176 | $14.6M | 15.3% | — |
| 4 | Point72 Asset Management, L.P. | 1,031,049 | $6.6M | 6.9% | — |
| 5 | AMERIPRISE FINANCIAL INC | 905,707 | $5.8M | 6.1% | DOUBLED +7775.7% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 715,965 | $4.6M | 4.8% | — |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 604,500 | $3.9M | 4.0% | ADD +77.4% |
| 8 | MARSHALL WACE, LLP | 581,471 | $3.7M | 3.9% | TRIM -25.4% |
| 9 | BlackRock, Inc. | 510,806 | $3.3M | 3.4% | TRIM -53.3% |
| 10 | FMR LLC | 392,500 | $2.5M | 2.6% | DOUBLED +11560.2% |
| 11 | TD ASSET MANAGEMENT INC | 382,648 | $2.5M | 2.6% | ADD +52.4% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 324,588 | $2.1M | 2.2% | — |
| 13 | TWO SIGMA INVESTMENTS, LP | 316,012 | $2.0M | 2.1% | DOUBLED +431.1% |
| 14 | STATE STREET CORP | 263,768 | $1.7M | 1.8% | NEAR_EXIT -77.4% |
| 15 | Hudson Bay Capital Management LP | 228,817 | $1.5M | 1.5% | — |
| 16 | MORGAN STANLEY | 200,136 | $1.3M | 1.3% | DOUBLED +1005.2% |
| 17 | DEUTSCHE BANK AG\ | 194,773 | $1.3M | 1.3% | — |
| 18 | GOLDMAN SACHS GROUP INC | 191,442 | $1.2M | 1.3% | — |
| 19 | DIMENSIONAL FUND ADVISORS LP | 155,642 | $1.0M | 1.0% | DOUBLED +571.1% |
| 20 | CITADEL ADVISORS LLC | 148,021 | $951.8K | 1.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | TRIM | 6,306,127 | 4,644,957 | -26.3% | $29.9M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | DOUBLED | 11,500 | 905,707 | +7775.7% | $5.8M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 340,700 | 604,500 | +77.4% | $3.9M | 2026-Q1 |
| TD ASSET MANAGEMENT INC | ADD | 251,050 | 382,648 | +52.4% | $2.5M | 2026-Q1 |
| MORGAN STANLEY | DOUBLED | 18,108 | 200,136 | +1005.2% | $1.3M | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | 23,192 | 155,642 | +571.1% | $1.0M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | 65,734 | 139,304 | +111.9% | $895.7K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 1,106,617 | 79,924 | -92.8% | $513.9K | 2026-Q1 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 20,881 | 40,881 | +95.8% | $262.9K | 2026-Q1 |
| Invesco Ltd. | ADD | 28,231 | 36,932 | +30.8% | $237.5K | 2026-Q1 |
| OMERS ADMINISTRATION Corp | ADD | 26,500 | 33,300 | +25.7% | $214.1K | 2026-Q1 |
| CWM, LLC | TRIM | 127 | 43 | -66.1% | — | 2025-Q4 |
| MARSHALL WACE, LLP | TRIM | 656,653 | 489,912 | -25.4% | $1.8M | 2025-Q4 |
| FMR LLC | DOUBLED | 3,367 | 392,600 | +11560.2% | $1.4M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 216,867 | 340,700 | +57.1% | $1.2M | 2025-Q4 |
| CWM, LLC | NEAR_EXIT | 2,989 | 127 | -95.8% | — | 2025-Q3 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | ADD | 4,675,000 | 6,306,127 | +34.9% | $15.1M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 36,891 | 1,131,888 | +2968.2% | $2.7M | 2025-Q3 |
| BlackRock, Inc. | TRIM | 881,388 | 411,292 | -53.3% | $983.0K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 76,934 | 408,598 | +431.1% | $976.5K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 38,100 | 216,867 | +469.2% | $518.3K | 2025-Q3 |
| BARCLAYS PLC | DOUBLED | 2,114 | 54,311 | +2469.1% | $189.5K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 24,088 | 16,651 | -30.9% | $39.8K | 2025-Q3 |
| FMR LLC | TRIM | 8,438 | 3,367 | -60.1% | $8.0K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 268,371 | 1,433 | -99.5% | $3.4K | 2025-Q3 |
12 unique insiders with 25 transactions. Net insider value: $37.5K ($250.0K bought, $212.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | SIEGALL CLAY B | Director | BUY | 62,500 | $4.00 | $250.0K |
| Jun 8, 2026 | Ashiya Mona | Director | CONVERT | 15,366,490 | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | CONVERT | 15,366,490 | — | — |
| Jun 8, 2026 | ORBIMED ADVISORS LLC | Director | CONVERT | 15,366,490 | — | — |
| Jun 8, 2026 | ORBIMED ADVISORS LLC | Director | CONVERT | 15,366,490 | — | — |
| May 29, 2026 | Ashiya Mona | Director | AWARD | 81,000 | — | — |
| May 29, 2026 | SIEGALL CLAY B | Director | AWARD | 81,000 | — | — |
| May 29, 2026 | Golumbeski George | Director | AWARD | 81,000 | — | — |
| May 29, 2026 | Gibson Neil W | Director | AWARD | 81,000 | — | — |
| May 29, 2026 | Baker Daniel G. | Director | AWARD | 81,000 | — | — |
| May 29, 2026 | Boudreau Helen M | Director | AWARD | 81,000 | — | — |
| May 22, 2026 | SIEGALL CLAY B | Director | EXERCISE | 128,054 | — | — |
| May 22, 2026 | SIEGALL CLAY B | Director | AWARD | 128,054 | $1.08 | $138.9K |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | EXERCISE | 5,122 | — | — |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | AWARD | 5,122 | $1.08 | $5.6K |
| May 15, 2026 | Stout Stephen | See Remarks | AWARD | 12,805 | $1.08 | $13.9K |
| May 15, 2026 | Stout Stephen | See Remarks | EXERCISE | 12,805 | — | — |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer | AWARD | 25,610 | $1.08 | $27.8K |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer | EXERCISE | 25,610 | — | — |
| May 12, 2026 | Pandite Arundathy N. | Chief Medical Officer | SELL | 30,000 | $6.61 | $198.3K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | EXERCISE | 2,032 | $3.57 | $7.3K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | SELL | 2,032 | $7.01 | $14.2K |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | AWARD | 64,027 | $1.08 | $69.4K |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | EXERCISE | 64,027 | — | — |
| May 10, 2026 | Stout Stephen | See Remarks | TAX W/H | 968 | $6.85 | $6.6K |
12 SEC filing reports analyzed. Sentiment: 2 bullish, 4 bearish, 0 mixed, 6 neutral. Avg impact: 4.4/10.
BEARISH
8-K
6/10
Shattuck Labs closed a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded
Jun 11, 2026
BEARISH
INST-CLUSTER
4/10
This 13F institutional cluster for Shattuck Labs (STTK) reveals one mega-passive buyer (Bank of Amer
Jun 11, 2026
BEARISH
424B5
6/10
Shattuck Labs is conducting a $75M underwritten public offering of 10.9M common shares and 7.9M pre-
Jun 11, 2026
BEARISH
424B5
6/10
Shattuck Labs filed a preliminary prospectus supplement for an underwritten public offering of commo
Jun 9, 2026
BULLISH
8-K
6/10
Shattuck Labs announced positive Phase 1 data for SL-325 (DR3 blocking antibody) showing low immunog
Jun 9, 2026
NEUTRAL
8-K
3/10
Shattuck Labs held its 2026 Annual Meeting on May 28, 2026. Stockholders approved an amendment and r
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
Two STTK insiders (CMO and CTO) sold a combined $212K in open-market sales on May 12, 2026, followin
May 18, 2026
NEUTRAL
CLUSTER
3/10
Two senior executives at Shattuck Labs (CMO and CTO) sold a combined $212K in open-market shares on
May 15, 2026
NEUTRAL
8-K
3/10
Shattuck Labs reported Q1 2026 net loss of $0.13 per share, slightly better than consensus of -$0.14
May 7, 2026
BULLISH
PRESS-RELEASE
5/10
Shattuck Labs reported Q1 2026 EPS of -$0.12, beating consensus of -$0.13 by 9.1%, with zero revenue
May 7, 2026
NEUTRAL
DEFA14A
3/10
Shattuck Labs is holding its annual shareholder meeting to vote on director elections, auditor ratif
Apr 8, 2026
NEUTRAL
8-K
5/10
Shattuck Labs reported full-year 2025 financial results showing reduced net loss of $48.8 million (d
Mar 5, 2026
Current analyst consensus: Strong Buy (86% buy). Based on 14 analysts: 3 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$14.83 mean target
+200.3% upside
Strong Buy (1.25)
$10.00 Low
$18.00 High
| Metric | Value |
|---|---|
| Current Price | $4.94 |
| Target Low | $10.00 |
| Target Mean | $14.83 |
| Target Median | $16.00 |
| Target High | $18.00 |
| # Analysts | 6 |
| Recommendation | Strong Buy (1.25) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.13 | $-0.18 | $-0.09 | 45.1% | +3.9% | 1↑ 1↓ | $0.0B | 0.0% | 7 |
| Next Q 2026-09-30 |
$-0.12 | $-0.21 | $-0.08 | 11.7% | +4.3% | 1↑ 1↓ | $0.0B | -100.0% | 7 |
| Current FY 2026-12-31 |
$-0.50 | $-0.79 | $-0.38 | 28.5% | -8.2% | 0↑ 3↓ | $0.0B | -100.0% | 7 |
| Next FY 2027-12-31 |
$-0.52 | $-0.88 | $-0.34 | -3.0% | -0.8% | 0↑ 1↓ | $0.0B | 0.0% | 7 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.132 | |
| 7d ago | $-0.137 | +0.005 |
| 30d ago | $-0.137 | +0.005 |
| 60d ago | $-0.128 | -0.004 |
| 90d ago | $-0.128 | -0.004 |
6 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 9, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Jun 8, 2026 | Needham | MAINTAIN | Buy | Buy |
| Jun 8, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 5, 2026 | Citigroup | UPGRADE | Neutral | Buy |
| May 8, 2026 | Wedbush | MAINTAIN | Outperform | Outperform |
| Apr 27, 2026 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Apr 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Mar 13, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Mar 6, 2026 | Wedbush | MAINTAIN | Outperform | Outperform |
| Jan 28, 2026 | Piper Sandler | INITIATE | — | Overweight |
| Jan 6, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| May 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 3 | 8 | 2 | 0 | 0 | 85% | |
| Mar 1, 2026 | 3 | 7 | 3 | 0 | 0 | 77% | |
| Feb 1, 2026 | 3 | 7 | 3 | 0 | 0 | 77% | |
| Jan 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 10, 2026
offering
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
<p>AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-st
Jun 9, 2026
offering
Shattuck Labs, Inc. Announces Proposed Public Offering
<p>AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-st
Jun 8, 2026
other
Shattuck Labs Announces Phase 1 Results for SL-325
<p>AUSTIN, TX and DURHAM, NC, June 08, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biote
Jun 8, 2026
short_volume
Short Volume: STTK — 61.6% short (1.4M / 2.2M)
Short: 1,375,886 | Exempt: 80,307 | TRF Vol: 2,233,648 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
routine
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
<p align="left">AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage bi
May 13, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-05-13
May 7, 2026
earnings
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
<p align="justify">AUSTIN, Texas and DURHAM, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a
May 4, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-05-04
Apr 29, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-04-29
Mar 17, 2026
earnings_calendar
STTK Q4 2025 Earnings After Market Close — 2026-03-17
Mar 5, 2026
earnings
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
<p align="justify">AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK),